Saturday, November 11, 2017 9:25:49 AM
This whole ELTP story over the past few years has been a tug of war between perceptions and delusions.
No one here can dispute that those that traded ELTP have been proven out to be more wise than "Buy, Hold and Accumulate".
Despite having to pay taxes. And booking "chump change."
Those who have unfortunately never traded have no choice but to try to convince themselves that they are not still holding a losing investment. Years ago, I used to do the same thing when I got overly committed to a stock idea that just was not panning out. The cycle of averaging down continued and ate up my investable capital so I could not buy into other promising companies.
Does ANYONE here really believe that the Conference Call was so positive that you would buy in now--with tax loss selling starting? There is no rush to buy ELTP. I bet you could buy in January, after tax loss selling, and still get a price around .08 or lower.
This Conference Call is probably the last piece of news we are going to get out of ELTP until the New Year.
No one here can dispute that those that traded ELTP have been proven out to be more wise than "Buy, Hold and Accumulate".
Despite having to pay taxes. And booking "chump change."
Those who have unfortunately never traded have no choice but to try to convince themselves that they are not still holding a losing investment. Years ago, I used to do the same thing when I got overly committed to a stock idea that just was not panning out. The cycle of averaging down continued and ate up my investable capital so I could not buy into other promising companies.
Does ANYONE here really believe that the Conference Call was so positive that you would buy in now--with tax loss selling starting? There is no rush to buy ELTP. I bet you could buy in January, after tax loss selling, and still get a price around .08 or lower.
This Conference Call is probably the last piece of news we are going to get out of ELTP until the New Year.
Successful Trading is the art of minimizing long term risk and maximizing capital allocation.
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
